Jefferies resumed coverage on Adicet Bio with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for ACET
Across the 8 sessions after earlier ACET headlines, the stock closed higher 4 times and lower 4 times, with a median move of 3.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ACET | SPY |
|---|---|---|---|
| Mar 13, 2026 | Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress | +2.4% | -0.6% |
| Jan 30, 2026 | Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 | -6.0% | -0.3% |
| Jan 7, 2026 | Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones | +5.0% | -0.3% |
| Dec 26, 2025 | Adicet Bio Announces Reverse Stock Split | +0.2% | -0.0% |
| Nov 28, 2025 | Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | +7.8% | +0.5% |
| Nov 6, 2025 | Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates | -1.9% | -1.1% |
Quantisnow market dataNASDAQ
ACET
Adicet Bio Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for ACET
Full ACET profile on Quantisnow Follow ACET and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time